According to an international health organization declared a test vaccine against Ebola virus in September this year will be tested in the United Kingdom in healthy volunteers body.
The latest Ebola virus vaccine is expected next month will begin testing healthy volunteers.
According to World Health Organization (WHO) says the outbreak of the Ebola virus could lead to two million people have been infected and is expected to last several months. The latest figures show that there are already more than 1550 people have died of Ebola virus, there are more than 3000 cases diagnosed patients, most patients are located in Guinea, Liberia and Sierra Leone.
Researchers are now developing a test vaccine against Ebola virus, and plans to start in September tested in healthy volunteers. Experts Wellcome Trust, said that once the application is started ethics will be tested through. If this vaccine works well, the study will be extended to West Africa, Gambia and Mali.
The researchers hope that the vaccine can prevent these countries allow people infected with the virus, but first of all to the uninfected population for this vaccine to be tested. Leader Dr. Jeremy Farrar Wellcome Trust, said: “This Ebola virus has been proved to be very difficult to control, currently only on the efficacy and effectiveness of the vaccine can be assessed.”
This vaccine contains a protein that Ebola virus enters the body will trigger an immune system response. The first phase of the study will be tested in 60 healthy volunteers. If the vaccine proved safe and effective, then it will be used for the Gambia and Mali, 80 volunteers. By 2015, this vaccine may be more widely used in the country of these outbreaks.
Dr. Moncef Slaoui GlaxoSmithKline said: “In the absence of successful research and development to ensure that the premise of a new vaccine is very complex and is still in the initial stage of Ebola virus vaccine research but research process is very order. encouraging, we will synergy World Health Organization and partners to make the greatest efforts to accelerate the development speed, and find out which is a vaccine to control the outbreak of the Ebola virus and the future. “